(Q44356753)

2 December 2017

title

Effect of pharmacist involvement on patient reporting of adverse drug reactions: first Italian study (English)

1 reference

2 December 2017

0 references

1 reference

Roberto Leone

1

1 reference

2 December 2017

Ugo Moretti

2

1 reference

2 December 2017

Paola D'Incau

3

1 reference

2 December 2017

Anita Conforti

4

1 reference

2 December 2017

Lara Magro

5

1 reference

2 December 2017

Riccardo Lora

6

1 reference

2 December 2017

Giampaolo Velo

7

1 reference

2 December 2017

publication date

1 April 2013

1 reference

2 December 2017

1 reference

2 December 2017

volume

36

1 reference

2 December 2017

issue

4

1 reference

2 December 2017

page(s)

267-276

1 reference

Patient views and experiences of making adverse drug reaction reports to the Yellow Card Scheme in the UK.

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0028-8

Adverse drug reaction reporting in the UK: a retrospective observational comparison of yellow card reports submitted by patients and healthcare professionals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0028-8

Motives for reporting adverse drug reactions by patient-reporters in the Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0028-8

The proportion of patient reports of suspected ADRs to signal detection in the Netherlands: case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0028-8

Consumer reporting of adverse drug reactions: a retrospective analysis of the Danish adverse drug reaction database from 2004 to 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0028-8

Consumers' reports of suspected adverse drug reactions volunteered to a consumer magazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0028-8

The missing voice of patients in drug-safety reporting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0028-8

Patient reporting of suspected adverse drug reactions: a review of published literature and international experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0028-8

Adverse drug reaction reporting by patients in the Netherlands: three years of experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0028-8

Under-reporting of adverse drug reactions : a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0028-8

Determinants of under-reporting of adverse drug reactions: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0028-8

Consumer adverse drug reaction reporting: a new step in pharmacovigilance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0028-8

Experiences with adverse drug reaction reporting by patients: an 11-country survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0028-8

A pharmacist model of perceived responsibility for drug therapy outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0028-8

Design and implementation of an educational partnership between community pharmacists and consumer educators in mental health care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0028-8

Systematic review of the incidence and characteristics of preventable adverse drug events in ambulatory care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0028-8

A method for estimating the probability of adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0028-8

The medical dictionary for regulatory activities (MedDRA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0028-8

Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? A review of the new EU legislation on pharmacovigilance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0028-8

Prevalence of adverse drug events in ambulatory care: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0028-8

Gender differences in drug responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0028-8

Women encounter ADRs more often than do men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0028-8

Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0028-8

Survey to assess public awareness of patient reporting of adverse drug reactions in Great Britain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0028-8

A patient's perspective: the impact of adverse drug reactions on patients and their views on reporting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0028-8

Patients as a direct source of information on adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0028-8

Comparing patients' and healthcare professionals' ADR reports after media attention: the broadcast of a Dutch television programme about the benefits and risks of statins as an example

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0028-8

How patient reporters identify adverse drug reactions: a qualitative study of reporting via the UK Yellow Card Scheme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0028-8

Patient versus healthcare professional spontaneous adverse drug reaction reporting: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-013-0028-8

Adverse drug reaction monitoring: comparing doctor and patient reporting for new drugs

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23475583

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S40264-013-0028-8

1 reference

2 December 2017

1 reference